Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report published on Thursday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Price Performance Evoke Pharma stock opened at $4.43 on Thursday. Evoke Pharma has a 1-year low of $3.54 and a 1-year high of […]

Leave a Reply

Your email address will not be published.

Previous post Iris Energy (NASDAQ:IREN) Given New $23.00 Price Target at Cantor Fitzgerald
Next post Financial Contrast: Paycom Software (NYSE:PAYC) vs. Take-Two Interactive Software (NASDAQ:TTWO)